Based in Changsha, Hunan Province, Sansure Biotech develops and produces nucleic acid extraction kits, real-time PCR diagnostic and research kits, and fluorescence systems for molecular diagnosis and genetic testing. The company offers a full range of integrated solutions that include COVID-19 detection solutions, which have been widely used in nearly 160 countries worldwide. Sansure Biotech's solutions are compatible with most PCR detection instruments and lab environments, and the company has over 100 products with global registrations, including infectious diseases, cancer, maternal and child health, blood screening, emerging infectious diseases prevention and control, and chronic disease management. The company is committed to R&D and technical service, with over 40% of its employees working in those departments.